Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

a Randomized Controlled Experimental Design That Uses a Pretest-Posttest Control Group Model.

NCT06380231 is registered in ClinicalTrials.gov with Istanbul Rumeli University as lead sponsor.

NCT NCT06380231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06380231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
a Randomized Controlled Experimental Design That Uses a Pretest-Posttest Control Group Model.
Lead sponsor
Istanbul Rumeli University
Phase
Not applicable
Overall status
Completed
Start date
November 1, 2019
Completion date
December 1, 2020
Enrollment
76 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kangaroo-mother care